MedCap AB (publ) (STO:MCAP)
443.00
-14.00 (-3.06%)
May 13, 2025, 5:29 PM CET
MedCap AB Revenue
MedCap AB had revenue of 493.80M SEK in the quarter ending March 31, 2025, with 6.95% growth. This brings the company's revenue in the last twelve months to 1.84B, up 10.11% year-over-year. In the year 2024, MedCap AB had annual revenue of 1.81B with 13.74% growth.
Revenue (ttm)
1.84B
Revenue Growth
+10.11%
P/S Ratio
3.72
Revenue / Employee
3.23M
Employees
592
Market Cap
6.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.81B | 218.30M | 13.74% |
Dec 31, 2023 | 1.59B | 465.00M | 41.37% |
Dec 31, 2022 | 1.12B | 197.70M | 21.34% |
Dec 31, 2021 | 926.30M | 98.30M | 11.87% |
Dec 31, 2020 | 828.00M | 70.60M | 9.32% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Apr 30, 2017 | Pro | Pro | Pro |
Apr 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.24B |
Sectra AB | 3.30B |
Getinge AB | 35.57B |
Camurus AB | 1.87B |
Medicover AB | 23.56B |
AddLife AB | 10.42B |
Vitrolife AB | 3.61B |
Vimian Group AB | 4.24B |